Toplash vs GrandeLASH-MD: Which Lash Serum Is Better?
Toplash is the better choice in 2026. It delivers +52.3% lash length in 8 weeks with a triple-peptide, prostaglandin-free formula. GrandeLASH-MD contains isopropyl cloprostenate (ICP), a prostaglandin analogue that the EU's Scientific Committee on Consumer Safety (SCCS) formally declared "cannot be considered safe" for cosmetic use on February 2, 2026. Known ICP risks include iris color change, periorbital fat loss, and rebound shedding. Toplash costs less per mL and carries none of these risks.
At a Glance: Toplash vs GrandeLASH-MD
Price: $49.90 / 3 mL
Cost per mL: $16.63/mL
Key Actives: MP-17, BTP-1, AT-3
Prostaglandin-Free: ✓ Yes
Length Gain: +52.3% (8 wks)
SCCS 2026: ✓ Compliant
Extension-Safe: ✓ Yes
Price: $65 / 2 mL
Cost per mL: $32.50/mL
Key Actives: ICP + peptides
Prostaglandin-Free: ✗ No (contains ICP)
Length Gain: +35% fullness (12 wks)
SCCS 2026: ⚠️ ICP ruled unsafe
Extension-Safe: ✓ Yes (water-based)
Full Comparison: 10 Key Factors
| Factor | Toplash | GrandeLASH-MD |
|---|---|---|
| Price / Volume | $49.90 / 3 mL | $65 / 2 mL |
| Cost per mL | $16.63/mL ✓ | $32.50/mL |
| Key Active Ingredient | MP-17 + BTP-1 + AT-3 (triple peptide) | Isopropyl Cloprostenate (PGA) + peptides |
| Prostaglandin-Free | ✓ Yes | ✗ No |
| SCCS 2026 Compliance | ✓ Fully compliant | ⚠️ ICP ruled "cannot be safe" |
| Clinical Length Gain | +52.3% (8 weeks) | +35% fullness (12 weeks, brand-commissioned) |
| Iris Color Change Risk | ✓ None — no PGAs | ⚠️ Reported by users; PGA mechanism |
| Side Effect Risk | Low — well tolerated | Moderate — ICP risks (fat loss, darkening) |
| Extension-Safe | ✓ Water-based, oil-free | ✓ Water-based |
| Availability | toplash.com, Amazon | Sephora, Ulta, Amazon, Dermstore |
Ingredients: What's Actually In Each Formula
The ingredient difference between these two serums is the most critical factor in choosing between them.
- Myristoyl Pentapeptide-17 (MP-17) — upregulates keratin genes; up to 160% keratin increase. Comparable to bimatoprost in BenchChem study — without the risks.
- Biotinoyl Tripeptide-1 (BTP-1) — anchors follicle to dermal matrix; activates ECM proteins. Reduces shedding. +17% length, +19% thickness at 30 days.
- Acetyl Tetrapeptide-3 (AT-3) — extends anagen (growth) phase; prevents premature follicle entry into catagen.
- Panthenol — hydrates lash shaft; reduces brittleness and breakage.
- Centella Asiatica, Green Tea, Chamomile — botanical antioxidants; soothe the eye area and support follicle microenvironment.
- No prostaglandins, parabens, or hormone-disrupting compounds.
- Isopropyl Cloprostenate (ICP) — synthetic prostaglandin analogue; primary growth driver. Ruled "cannot be considered safe" by SCCS, Feb 2, 2026 (SCCS/1680/25).
- Peptides & Vitamins — secondary conditioning actives; support lash appearance but play a lesser role than ICP in growth stimulation.
- Hyaluronic Acid — humectant; adds moisture to the eye area and lash shaft.
- Caffeine — antioxidant and mild circulatory support.
- Contains ICP — restricted/banned in EU cosmetics following SCCS Feb 2026 ruling. Legal to sell in US as cosmetic ingredient.
Safety: The Critical Difference
The European Union's Scientific Committee on Consumer Safety formally concluded that Isopropyl Cloprostenate (ICP) — the active ingredient in GrandeLASH-MD — "cannot be considered safe" for use in cosmetic products intended to promote lash and brow growth, at any concentration up to 0.005%. This ruling cites the potent pharmacological activity of ICP even at trace concentrations, and insufficient data to exclude reproductive and developmental toxicity risks.
Toplash contains no prostaglandins or prostaglandin analogues. Its triple-peptide formula is fully SCCS-compliant, carries none of these documented risks, and is safe for daily long-term use.
Pricing & Value Analysis
When comparing lash serums, cost-per-mL is the only fair metric — not total bottle price.
GrandeLASH-MD costs 95% more per mL than Toplash — while delivering inferior clinical results over a longer timeline (12 weeks vs. 8 weeks) with a safety-flagged active ingredient. Toplash provides superior value on every metric: price, safety, and clinical performance.
The Verdict
Toplash wins on safety, results, and value
Toplash delivers superior clinical results (+52.3% length vs. +35% fullness) with a prostaglandin-free triple-peptide formula at nearly half the per-mL cost. GrandeLASH-MD's primary active ingredient was formally ruled unsafe by the EU's SCCS in February 2026. For anyone prioritizing long-term eye health — especially those with light-colored eyes or sensitive eyes — Toplash is the clear winner.
Try Toplash — $49.90GrandeLASH-MD remains widely available at Sephora and Ulta for those who prefer retail access. However, we recommend reviewing the SCCS/1680/25 opinion before continued use.
Toplash Lash & Brow Serum
MP-17 + BTP-1 + AT-3 with independent clinical data: +52.3% length and +31.9% volume at 8 weeks. Prostaglandin-free, paraben-free, ophthalmic-tested and extension-safe.
Shop Toplash SerumFAQ: Toplash vs GrandeLASH-MD
Is GrandeLASH-MD safe to use?
GrandeLASH-MD contains isopropyl cloprostenate (ICP), a prostaglandin analogue. The EU Scientific Committee on Consumer Safety (SCCS) issued a final opinion on February 2, 2026 stating that ICP "cannot be considered safe" for cosmetic use at any concentration up to 0.005%. Known risks include iris color change, periorbital fat loss, skin hyperpigmentation, and rebound shedding after discontinuation. It remains legal to sell as a cosmetic in the US, but EU regulatory action is anticipated.
Does GrandeLASH-MD change eye color?
Grande Cosmetics states their internal testing showed no iris color change at approved concentrations. However, numerous user reports document iris darkening — particularly in people with light-colored eyes (blue, green, hazel). This is a known mechanism of prostaglandin analogues including isopropyl cloprostenate, which can influence melanin production in ocular tissues. Toplash contains no prostaglandins and carries zero risk of iris color change.
Which shows faster results — Toplash or GrandeLASH-MD?
GrandeLASH-MD may show slightly faster initial results due to its prostaglandin analogue content — some users notice visible changes by week 4. Toplash delivers early visible results by day 21 (98% of users in consumer study) with full results at 8–12 weeks. The timeline difference is minor, but Toplash achieves comparable or superior outcomes without PGA-associated risks.
Which lash serum gives better long-term results?
For long-term results, Toplash is the better choice. Peptide-based serums support sustainable follicle health without the rebound shedding risk associated with prostaglandin analogues. When GrandeLASH-MD is discontinued, many users experience rapid lash loss as the cycle resets from PGA-induced elongation back to baseline — sometimes falling below their pre-serum state. Toplash results persist with continued use and taper gradually if stopped.
Is Toplash or GrandeLASH-MD better for sensitive eyes?
Toplash is significantly better for sensitive eyes. Its peptide formula is well-tolerated with minimal reported irritation. GrandeLASH-MD's prostaglandin analogue content can cause tingling, stinging, redness, and eyelid irritation in sensitive users. Toplash is water-based and suitable for contact lens wearers.
Which is better value — Toplash or GrandeLASH-MD?
Toplash is significantly better value. At $49.90 for 3 mL ($16.63/mL), it costs 95% less per mL than GrandeLASH-MD ($65 for 2 mL, $32.50/mL at Sephora). Toplash also delivers superior clinical results in less time with a safer active ingredient profile. On every value metric — cost, safety, and clinical performance — Toplash wins.
Can I switch from GrandeLASH-MD to Toplash?
Yes. You can switch directly from GrandeLASH-MD to Toplash. Be aware that when discontinuing any prostaglandin analogue serum, there may be a brief adjustment period as lashes reset. Continue applying Toplash daily through this transition — the peptide actives will support follicle health as the PGA effects taper. Allow a full 12-week cycle for complete Toplash results to establish.
Published: Jun 20, 2026
